We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+2.72%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$522M
AUM Growth
+$11.4M
Cap. Flow
+$1.47M
Cap. Flow %
0.28%
Top 10 Hldgs %
50.26%
Holding
72
New
1
Increased
37
Reduced
25
Closed
–

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$927K
2
AMZN icon
Amazon
AMZN
+$504K
3
NSC icon
Norfolk Southern
NSC
+$492K
4
CNI icon
Canadian National Railway
CNI
+$401K
5
NVDA icon
NVIDIA
NVDA
+$366K

Top Sells

Rank Stock Value
1
PAYX icon
Paychex
PAYX
+$1.2M
2
AAPL icon
Apple
AAPL
+$854K
3
MRK icon
Merck
MRK
+$364K
4
BDX icon
Becton Dickinson
BDX
+$353K
5
SYK icon
Stryker
SYK
+$341K

Sector Composition

Rank Sector Weight
1 Technology 28.59%
2 Healthcare 18.89%
3 Communication Services 13.26%
4 Consumer Discretionary 10.89%
5 Financials 10.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RTX icon
26
RTX Corp
RTX
$290B
$6.93M 1.33%
80,602
+2,713
+3% +$232K
STZ icon
27
Constellation Brands
STZ
$22.2B
$6.54M 1.25%
31,004
+464
+2% +$101K
ISRG icon
28
Intuitive Surgical
ISRG
$127B
$5.31M 1.02%
16,020
+81
+0.5% +$27.2K
JNJ icon
29
Johnson & Johnson
JNJ
$618B
$5.25M 1%
32,379
-555
-2% -$94.7K
REGN icon
30
Regeneron Pharmaceuticals
REGN
$78.5B
$4.75M 0.91%
7,856
+1,493
+23% +$927K
CL icon
31
Colgate-Palmolive
CL
$73.1B
$4.41M 0.84%
57,955
-1,280
-2% -$102K
CRM icon
32
Salesforce
CRM
$151B
$4.41M 0.84%
16,255
+527
+3% +$134K
HD icon
33
Home Depot
HD
$331B
$4.2M 0.8%
12,800
-275
-2% -$90.3K
MCD icon
34
McDonald's
MCD
$192B
$3.86M 0.74%
16,032
– –
MSFT icon
35
Microsoft
MSFT
$3.45T
$3.35M 0.64%
11,878
+750
+7% +$218K
PG icon
36
Procter & Gamble
PG
$336B
$3.27M 0.63%
23,327
+73
+0.3% +$10.3K
JPM icon
37
JPMorgan Chase
JPM
$935B
$3.08M 0.59%
18,813
+31
+0.2% +$4.86K
AMT icon
38
American Tower
AMT
$80.8B
$3.08M 0.59%
11,635
+178
+2% +$50.7K
SYY icon
39
Sysco
SYY
$40.8B
$2.25M 0.43%
28,776
-450
-2% -$34.3K
DEO icon
40
Diageo
DEO
$49B
$2.23M 0.43%
11,545
+75
+0.7% +$14.5K
HON icon
41
Honeywell
HON
$77B
$1.8M 0.35%
9,011
+1,607
+22% +$343K
MDLZ icon
42
Mondelez International
MDLZ
$79.5B
$1.54M 0.29%
26,536
+729
+3% +$45.4K
NEE icon
43
NextEra Energy
NEE
$181B
$1.52M 0.29%
19,200
+728
+4% +$58.7K
ABBV icon
44
AbbVie
ABBV
$443B
$1.38M 0.26%
12,789
+4
+0% +$457
QCOM icon
45
Qualcomm
QCOM
$155B
$1.27M 0.24%
9,835
-164
-2% -$23.3K
ADBE icon
46
Adobe
ADBE
$99.5B
$1.22M 0.23%
2,109
+2
+0.1% +$1.26K
WMT icon
47
Walmart Inc
WMT
$885B
$1.14M 0.22%
24,570
-600
-2% -$28.9K
CMCSA icon
48
Comcast
CMCSA
$85B
$698K 0.13%
12,466
+2,525
+25% +$147K
NVS icon
49
Novartis
NVS
$297B
$693K 0.13%
8,449
– –
TGT icon
50
Target
TGT
$65.6B
$650K 0.12%
2,840
– –
1
2
3

Similar funds

TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $725M AUM 11.7% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
SCM
SKBA Capital Management San Francisco, California $728M AUM 12.18% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $729M AUM 15.61% 1-Year Est. Return
FAN
Financial Advisors Network Tustin, California $724M AUM 14.91% 1-Year Est. Return
TFHU
TLT Family Holdco ULC Toronto $724M AUM 24.23% 1-Year Est. Return
AGAM
Avalon Global Asset Management San Francisco, California $724M AUM 52.97% 1-Year Est. Return

Dillon & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Dillon & Associates held 72 positions worth $522M, up 2.2% from $511M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 1.4%. Dillon & Associates opened 1 new position and made no exits, leaving the 72-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Communication Services.

  • Dillon & Associates's largest Q3 2021 buy was Align Technology: 320 shares worth $213K.
  • Dillon & Associates added most to Regeneron Pharmaceuticals in Q3 2021, an estimated $927K increase.
  • Dillon & Associates's biggest Q3 2021 reduction was Paychex, cutting an estimated $1.2M.
  • Dillon & Associates's ten largest holdings make up 50% of its $522M portfolio in Q3 2021.
  • Dillon & Associates opened 1 new position and closed 0 in Q3 2021.
  • Dillon & Associates's portfolio value rose 2.2% quarter-over-quarter to $522M.

Based on Dillon & Associates's 13F filing for Q3 2021, filed 28 Oct 2021.